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ABSTRACT
Background: The expansion of available vaccines in recent years has increased the overall costs of the
vaccine program and put pressure on providers responsible for vaccination. In England in 2016–17, GP
practices responsible for vaccinating their local population were paid £227 million. However, the costs to
general practice of delivering the program and the factors influencing these costs are unknown.
Therefore, the aim of this study was to evaluate the costs of delivering the routine vaccination program
at GP practices in England, to identify organizational factors impacting costs, and to compare these to
the funding received.
Methods: Time Driven Activity Based Costing was undertaken at a convenience sample of nine
geographically and socio-economically diverse GP practices in 2017–2018. Cost data were gathered
for the preceding year using a survey and clinical and administrative staff kept activity logs for a 2-week
period.
Results: The mean cost of delivering a childhood vaccination appointment was £18.20 (range £9.71-
£25.97) and an adult appointment cost £14.05 (range £7.59-£20.88), of which 75% was for staff, 24% for
facility costs and 1% for consumables. Organizational factors contributing to lower costs include: shorter
length of allocated appointment; greater use of administrative and reception staff; lower working time
for practice manager and practice nurse; and use of health-care assistants for adult vaccinations. The
costs identified are lower than payments at all practices.
Conclusions: Funding received for vaccination activities was higher than costs at included practices.
Several organizational factors have been identified that impact on program delivery costs that could be
modified.
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Introduction
Vaccination against infectious diseases is an extremely cost-
effective intervention,1 however, with the rapid expansion of
available vaccines in recent years,2,3 the costs to governments
and other payers for both vaccines, and the associated delivery
programs have been increasing as recommended schedules
have become increasingly complex. In England in 1990 the
routine vaccine schedule consisted of eight vaccinations
events for immunisation against eight infectious diseases, all
targeted at children or adolescents.4 The current schedule
involves 16 shots for children against 11 diseases, with
a further three in adolescents and four in adults (against
influenza, pneumococcal disease and shingles in older adults
and pertussis in pregnant women).5 All routine vaccinations
in England are provided free-of-charge to patients.
After nearly a decade of steady increases vaccination coverage
in England has started to decline, with multi-year reductions
observed in several important childhood vaccines, including
measles, mumps, and rubella (MMR) and diphtheria, tetanus,
pertussis and polio (DTaP/IPV) vaccines.6 These reductions in
coverage are particularly important in the context of the
substantial measles outbreak currently affecting many European
countries, including England.7,8 In addition, the national averages
do not reflect the significant and persistent regional variation,
where coverage both in London and other large urban centers is
significantly lower than other parts of the country (for example, in
2017 DTaP-IPV-Hib 12 months: England 93.4%, London 88.8%;
MMR2 5 years: England 87.6%, London 79.5%), which exists
alongside lower coverage in certain ethnic groups and in areas of
higher deprivation.9,10 For older adults, pneumococcal polysac-
charide vaccine was introduced in 2003 and mean coverage in
2018 was 69.5%, but with significant geographic variation, ranging
from 48.2% in the London Borough of Kensington and Chelsea to
78.1% in Knowsley (North West region.)11 Vaccination against
shingles was introduced in 2013 and cumulative mean coverage
remains low at 41.0%12
Funding
In England, GP practices are independent private organizations
that are contracted to provide health services to a defined popu-
lation through a nationally negotiated contract (the General or
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Personal Medical Services contract) by NHS England (NHSE),
the body responsible for commissioning primary health-care
services.13,14 Currently payments made to practices providing
vaccinations are not based on the costs of delivering vaccination
services, but instead on achieving outcomes defined within this
contract. Firstly, practices receive a ‘global sum’ capitation pay-
ment that is not related to activity, designed to fund ‘structural
costs’ for all services provided by the practice based on size.15 If
practices opt out of providing childhood vaccinations they
receive a deduction of 1–2% of this payment. Secondly, delivery
of some vaccines incurs an item-of-service payment, while
others are considered in groups and payment is received on
completion of a course, or when specified levels of coverage
are achieved as shown in Supplementary material 1 – Table
1.16 There is also an additional payment for timely vaccination
when children receive vaccines during the first 3 months of
eligibility. Finally, a small number are incentivized through the
Quality Outcomes Framework (QOF), a pay-for-performance
scheme (primarily influenza vaccine in clinical risk groups).17
These contracting arrangements are subject to annual
negotiations between the Department of Health and Social
Care (DHSC), NHSE and the General Practitioners
Committee of the British Medical Association.18 The thresh-
old targets have remained the same since the contract was
introduced in 2004; however, the fee-for-service payment has
been incrementally increasing over time, from £7.64 in 2013
to £10.06 in 2018, a 32% increase in 5 years, which has
increased the costs to the government of delivering the pro-
gram. In 2016–2017 NHSE paid GP practices £227 million for
activity related to vaccination (excluding QOF payments and
global sum payment).19
However, the system lacks transparency due to its com-
plexity, and payments to practices are not aligned with costs.
There are very few studies evaluating the costs to practices
associated with delivering vaccinations to determine the
appropriateness of payment levels. Together, these factors
make it extremely challenging to recommend changes to the
funding system that may improve coverage. Therefore, the
aim of this study is to describe and evaluate the costs of
delivering the routine vaccination program at GP practices
in England and to compare them with funding payments and
identify factors associated with differential costs between
practices.
Results
Following circulation of the study details, 14 practices retuned
expressions of interest. We excluded four practices as they were
geographically similar to already included practices, and one
did not complete data collection. Therefore, between May 2017
and February 2018, 9 practices completed the data collection
activities. Data collection commenced at the time of recruit-
ment. No practices collected data during the initiation of the
seasonal influenza campaign (September–October 2018). Their
characteristics are presented in Supplementary Material 2 –
Table 2. Detailed information on each practice is available in
the precursor study.20
Costing
The costs of delivering a single vaccination appointment dur-
ing the 2-week study period at each practice are presented in
Supplementary Material 3 – Table 3, alongside the number
and mean length of appointments at the practices.
The mean cost for a childhood appointment was £18.20
(95% CI £14.26-£22.15) and ranged from £9.71 at practice
D to £25.97 at practice A. Of the cost, 74.3% (£13.52) of the
mean total was staff costs and 24.4% (£4.44) facility and 1.4%
(£0.25) vaccination specific. Of the staff costs, 54.7% (£7.40)
was clinical and 45.3% (£6.12) administrative, of which 36.3%
(£2.22) was attributed to clinical staff and 63.7% (£3.90) to
administrative staff.
The mean cost for an adult appointment was £14.05 (95%
CI £11.03-£17.08) and ranged from £7.59 (H) to £20.88 (C).
The contributing costs were similar to those of childhood
appointments with 75.9% (£10.66) from staff, 23.4% (£3.29)
from facility, and 0.7% (£0.10) from specific. Of the staff costs,
a lower proportion was from clinical staff (41.2%, £4.40) due
to the shorter appointment times and thus a higher propor-
tion was from administration costs (58.8%, £6.26). A similar
proportion of the admin time was attributed to clinical staff
(36.2%, £2.27) and admin staff (63.8%, £4.00) as for childhood
appointments.
To preserve the anonymity of practices, the facility costs
are not being published separately; however, the overall
annual facility costs per registered patient ranged from £9.88
to £50.02 with a mean across the practices of £28.67 (95% CI
£20.86-£36.48). These costs are fixed and unchanged by the
vaccination program.
Vaccination specific costs
Most practice managers were not able to disaggregate the
consumables used in vaccination from their general orders
for the practice. However, two practices provided detailed
information on the cost of consumables (e.g. needles, syr-
inges) and detailed usage during appointments (D & J),
which ranged from £0.19 – £0.24 per childhood appointment
and <£0.10 for adult appointments with a single injection.
Practice managers were not able to disaggregate the costs of
providing and maintaining cold-chain (e.g. utilities and
fridges) from the overall facility costs and so these have not
been reported separately. Therefore, a nominal cost of £0.25
and £0.10 for consumables was added to each childhood and
adult vaccination appointment, respectively. Although it is
possible there is some variation of consumables used by
practice, it is not likely that this would be significant enough
to greatly affect overall appointment costs.
Cost per childhood vaccine
Part of practices’ remuneration for vaccinations is a fee-for-
service payment per vaccine. Thus, another way of considering
the costs is per vaccine delivered, rather than per appointment.
Childhood appointments vary in length, cost and the number
of vaccinations delivered (Supplementary Material 4 – Table 4).
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The appointments with the largest number of vaccinations
(8-week and 12-month) gave the lowest cost per vaccine
(£5.19 and £4.72, respectively), despite having the longest
appointment lengths. Currently, the fee-for-service payments
are not related to the costs at practice level as these were
previously not known. The costs borne by the practice range
from £4.72 to £9.55 per vaccine. Fee-for-service payments for
individual childhood vaccines (Table 1) range from £4.90 for
rotavirus to £10.06 for meningococcal group B, suggesting that
payments to practices exceed costs in this context.
Sensitivity analysis
The main area of the TDABC model with greatest uncertainty
is the weighting of appointment resource use in calculating
the FCCR. Sensitivity analysis around alternative weightings
are presented in Supplementary Material 5 – Table 5, which
shows that if GPs were allocated 4 times the resources of
nurses, vaccination appointment costs reduced by 4.5%. If
GP appointments and nursing appointments are weighted
equally, this increases vaccination appointment costs by
almost 25%.
Factors affecting costs
The underlying facility cost base of the practice made
a moderate difference to the overall totals, with contributions
ranging from 31.7% of the total childhood appointment cost
at practice J to 10.3% at D. However, these costs are largely
fixed and related to the underlying business structure and
locally negotiated contracts for premises and services, which
are outside the scope of this study.
The cost of staffing is the main variable cost, which is
dependent on three factors: task allocation, time spent and
salary costs. At the request of the practices we have not
published reported salary costs; however, the relative salary
cost at each of the practices is presented in Supplementary
Material 6 – Table 6. It was not possible to include the data
for administrators and receptionists due to the wide range in
job specifications and salary scales.
For childhood appointments, the lowest total clinical
staff cost was at practice D (£4.67), which was primarily
due to the low salary cost with an average appointment
length (13.9 min). Practice F had similarly low costs
(£4.88); however, this was due to very short appointments
(9.8 min), despite having higher than average clinical staff
costs. This was achieved by their system of a dedicated baby
clinic with two PNs and two HCAs with 5 min-allocated
appointments. The highest clinical cost (£10.86) was found
in practice C that had the longest appointment length (22
min) and slightly higher than average staff costs. Practice
G had high costs (£10.14) primarily due to higher staff
salaries in London, despite an average appointment length
(18.3 min). For adults, Practice E had the lowest clinical
cost due to the very short appointment length (6.8 min)
and low salary costs. Despite having both average salary
costs and average appointment length (9.1 min), practice
H had very low clinical costs (£2.92) due to the high use of
HCAs.
The total administration costs generally fell within
a relatively narrow range. The highest cost was found in
practices A (£8.83-£9.01) and C (£8.63). Practice A had the
smallest list size with a small management team, so the prac-
tice manager had a much larger role in data collection and
submission than elsewhere. Practice C had a relatively high
contribution from the practice nurse (£4.22, 48.9% admin
cost), particularly relating to data collection, submission, and
vaccine ordering. Both the London practices (G and J) had
relatively high costs from admin staff (£5.19, 79.8%; £5.84,
80.7%, respectively) as they had specialist administrative staff
to undertake the associated workload.
The lowest total admin cost was found in practices H and
D. Practice H had the lowest staff admin costs overall (£2.26),
despite relatively average staff salaries. This is due to the very
low cost of clinical admin time (£0.86) as much of the data
entry is undertaking during the baby clinic by one of the
HCAs. The practice also employs a specialist administrator
who undertakes most of the reminder, recall, ordering and
data entry, with little involvement from the PM or PN.
Effect of delivery model on cost
Supplementary Material 7 – Table 7 shows the relative cost of
each of the staffing components as compared to the mean cost
using standardized salaries, which removes the effect of dif-
ferential salary costs in different geographic regions. This
demonstrates that the delivery systems in place at the smaller
practices (A, B & C) are relatively costly. Smaller practices are
less likely to have administrators or specialist receptionists to
undertake the administrative workload, so instead this is
completed by the PN and PM, who have higher salaries.
Practice C is the most costly overall due to a combination of
long appointment times and a large role for both the PN and
PM in administration. In the case of practice B, the PN has
the highest administration cost, being almost double the mean
(1.97). These three smaller practices achieve high levels of
vaccine coverage alongside their high costs.
The lowest cost system is in practice H, which is around
40% lower than the mean for both childhood and adult
appointments. For childhood appointments, the clinical cost
is close to the mean (0.8), despite the shortest appointment
time (9.0 min) as there are two staves contributing to the cost
of each appointment, with the HCA undertaking preparation
and data entry alongside the nurse. This reduces the amount
of administration undertaken by PNs and the rest is under-
taken by a specialist administrator with a relatively lower cost
than the PM. Practice H also had the highest number of adult
vaccinations given by an HCA (60% of the total), which
meant that despite an average appointment length (9.1 min),
the relatively clinical cost was the lowest (0.72).
Practice F also had relatively lower costs for childhood
appointments, partly due to the short appointment length
(9.8 min), reducing the clinical cost to 60% of the mean,
and with a relatively low administrative cost (0.59) by using
an administrator. This practice has relatively good coverage of
childhood vaccinations, but low coverage of adult vaccina-
tions. Practice D had the lowest administrative cost due to the
large role for receptionists in both reminder/recall activities
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and data submission. Despite the relatively long appointment
times for adults in practice G (13.3 min), the cost was very
close to the mean (0.99) as 55% of these vaccinations were
given by an HCA during the study period.
Comparison with payments
Annual payments to the GP practices included in this study
were extracted from data from 2016 to 17 and are presented
in Supplementary Material 8 – Table 8 for each funding
stream.19 These payments integrate some activity that is not
included in this study (e.g. seasonal influenza), which creates
a challenge in making a direct comparison. However, esti-
mated costs have been compared to payments for total 1.
childhood, 3. rotavirus and shingles, and 4. meningitis vacci-
nation programs, excluding 2. influenza and pneumococcal
payments, which are reported together. The costs associated
with program delivery are lower than payments in all cases,
meaning that overall it is likely that payments are likely to
meet the costs associated with delivering the program.
Discussion
The purpose of this study was to calculate the costs associated
with delivering the routine vaccination program at GP practices
to identify factors impacting on costs and to compare this to
payments practices receive. Overall, the estimated operational
costs and payments at practice level suggest that payments cover
costs. Excluding cost variations outside an individual practice’s
purview (e.g. higher salary costs in London), organisational
factors that may contribute to lower costs include: shorter allo-
cated appointment length; greater use of administrative and
reception staff; less time spent by higher salaried staff (such as
the practice manager and practice nurse) for administration; and
use of HCAs for adult vaccinations. However, each of these
factors needs to be considered in the context of total GP practice
service delivery, which is outside the scope of this study, espe-
cially as there is currently no evidence for any association
between cost and coverage. Although this should be subject to
further investigation.
After standardizing for salary differentials, the larger prac-
tices in this sample had lower costs overall, due to higher use
of relatively less expensive administrators, receptionists, and
HCAs for administrative tasks. However, these practices also
had lower coverage overall, particularly the two large practices
in London, where coverage if childhood vaccinations is
known to be lower than other areas of England.6,9,10 Due to
the level of data collected from within a busy general practice,
the sample size was small. This means that the absolute costs
are unlikely to be generalizable to General Practices in
England more widely. The small sample size also precludes
regression analysis to evaluate the statistical significance of
any association with cost and coverage and these factors
should be evaluated on a larger sample. However, the under-
lying factors identified here (such as time spent, appointment
length and task allocation) are likely to be associated with cost
levels more widely. From the results presented here, we have
concluded that overall funding is likely to meet costs, this may
not be true for each component of the program. This is
particularly important as the cost of delivering each appoint-
ment varied across the practices 2.5-fold. It is also not clear in
the contracting documentation how much of the underlying
facility costs is expected to be covered by the ‘global sum’
capitation payment provided by NHSE to practices, which is
important as facility costs comprise around a third of the
overall childhood appointment cost for four of the practices
included here (A, E, F & J).
Cost comparison
To our knowledge no other studies have evaluated the costs
of delivering non-influenza routine adult vaccination
appointments; however, several studies have examined
childhood vaccination costs. One recent study conducted
in England used time-and-motion methods to record time
per activity within a childhood vaccination appointment.23
This reported a mean appointment time of 9.5 min (95% CI
7.7–11.3), with an additional 10.1 min of non-observed pre-
appointment preparation. This was similar to the time we
observed in practices F and H. The total cost described was
£11.90, which did not include any facility costs. The
equivalent mean cost of staff and specific costs in our
study is £13.77. Much of the administrative activity
involved in vaccination was not measured and instead
times was allocated following an interview with a nurse,
but did not involve any administrative or management
staff. No information was provided on the task allocation
or activities undertaken at each practice. A previous study
conducted in New Zealand in 2009, which used ABC to
analyse the vaccination delivery system at 24 practices,
found a mean cost per appointment of NZ$25.89 (range
NZ$14.38–32.50), which equates to £15.08 (range £8.38-
£18.93) when adjusted for inflation (to 2018) and converted
to British pounds.24,25
Task shifting
One of the ways of modifying the cost base of delivering the
program is to shift tasks between staff groups. The most
widely studied form of task shifting in primary care is from
doctors to nurses, where the evidence suggests that it can
reduce costs and improve preventive outcomes, but may also
result in increased number of return visits and longer
consultations.26–28 Within the context of this study, two
types of task-shifting may reduce costs when delivering the
vaccination program. The first is to shift some vaccination
activity from nurses to healthcare support workers (including
HCAs), who are able to give influenza, pneumococcal and
shingles vaccines to adults within a GP practice setting. For
each vaccination, they have to receive a Patient-Specific
Directive signed by a prescriber before the vaccine can be
given.29 HCAs were only used at three practices included in
this study (B, G, and H). Given the low levels of coverage of
adult vaccines at some of the practice included here, greater
used of HCAs may be a mechanism to achieve higher cover-
age, although this remains an un-studied area. It could also
reduce overall practice time spent on vaccination as HCA
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appointments were much shorter than most nursing appoint-
ments at the practices studied here.
The second type is to shift administrative activity from
nursing staff to administrative staff. Practices B, E, and F all
had high proportions of time spent on non-clinical tasks by
the PN (~55%), with higher associated costs, which was
mainly ordering and stocking vaccines. This had been shifted
to HCAs or administrators in several other practices, includ-
ing practice H which had one of the lowest cost systems
alongside a low proportion of nursing time spent on admin.
Practice G had shifted administrative activity from nurses to
administrative staff and had the lowest overall cost for admin
activities from the practice nurse, but relatively high costs for
admin costs overall. Further work needs to be done in this
area to evaluate the relative costs and benefits for making
recommendations on how task shifting could improve pro-
gram delivery.
Policy recommendations
At a local level, knowing the specific costs incurred by prac-
tices can then enable practice management to identify funds
available for vaccination that can be used to provide addi-
tional services in areas of low coverage and may act as an
incentive to increase volume of existing services where these
are revenue generating. This information can also be used at
high-cost practices to reduce costs overall and use the addi-
tional funds improve service delivery quality, including
improved administrative efficiency (e.g. implementation of
new electronic systems) to free up staff time for other activ-
ities. At national level the rationale for the amounts agreed
during GP contract negotiations is not made public; however,
knowledge of overall costs and factors associated with lower
costs can be used to determine adequate funding levels and
identify available funds for use within the system to improve
coverage, particularly in London and other urban areas, and
to reduce inequalities. Therefore, we recommend:
● Costing should be undertaken at a wider range of prac-
tices to confirm amounts and associations identified here.
● Accurate cost data should be used at national level to
determine appropriate funding levels for the program
and identify funds that can be used to provide additional
services to improve coverage and reduce inequalities.
● Where funding is higher than costs, practices should be
supported in using available funds to provide additional
cost-effective services in areas of lower coverage and
improve administrative efficiency to free up staff time
for other activities.
Limitations
This is a small, convenience sample of practices, which are
unlikely to be representative of all GP practices. No very small
or very large practices were included. The methods rely on
self-reporting of activities, which may be subject to reporting
bias. Activity logs were kept during different weeks at each
practice and activity is not even throughout the year. The
small sample size precluded statistical analysis of practice
characteristics with costs. This study only considers costs to
the GP practice and not to patients or society.
Conclusions
It is likely that funding covers costs associated with vaccine
program delivery at GP practices. However, this need con-
firming on a larger sample of practices. Organizational factors
that could be modified to reduce costs, including reducing
allocated appointment length; greater use of administrative
and reception staff; reduction in working time for the practice
manager and practice nurse for administration; and use of
HCAs for adult vaccinations. While it is not known if this
improves coverage, knowledge of costs and associated factors
can be used to identify potential cost savings within the
program to improve efficiency and allocate available funds
to additional activities to improve coverage and reduce
inequalities.
Methods
The purpose of the study methods is to quantify all the costs
incurred by the practice, including facility operating costs,
staffing, and consumables and allocate these to the activity
associated with delivering vaccinations during the 2-week
study period.
Sampling
The sampling method and characteristics of included prac-
tices are described in detail in the associated paper.20 We
recruited a sample of nine geographically and demographi-
cally diverse practices via the National Institute for Health
Research Clinical Research Network of more than 2,000 GP
practices signed up to a scheme of payment for participating
in research projects. We aimed to recruit a non-representative
convenience sample of 10 practices (due to our available
capacity) from a range of geographic and socio-economic
contexts. A £350 shopping voucher (£500 in London) was
provided to participating practices.
Consent and ethical approval
We gained written, informed consent from each participant
prior to commencing data collection. The study received
ethical approval from the London School of Hygiene and
Tropical Medicine Ethics Committee and the NHS Health
Research Authority (project ID 212278).
Time-driven activity-based costing
Costing routine vaccine program delivery has previously been
undertaken in New Zealand using Activity Based Costing
(ABC) methods,25,30 which allocate costs to complex processes
within organizations to identify underlying cost drivers.31
More recently, ABC has been updated to reduce the admin-
istrative burden of data collection and is now termed Time-
Driven Activity-Based Costing (TDABC).32–34 This method
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has been applied to evaluate the costs of complex health
service delivery in both primary and secondary care.34
TDABC involves a 7-step process for identifying and allo-
cating costs.35 The results of steps 1–4 are presented in
a precursor paper using the same sample.20 In summary, the
condition under analysis is defined as a patient registered at
a GP practice who is eligible for routine vaccination. Seasonal
vaccines (including influenza), other non-routine vaccines
(e.g. for travel) and any vaccinations not given at GP practices
are excluded. The Care Delivery Value Chain (CDVC; a visual
representation of the main activities involved in providing
vaccination) and a detailed process map have been developed
in the linked paper.20
This study focusses on the results of steps 5–7. In step 5,
data are generated on all vaccination-related activity under-
taken in the 2-week study period and all costs incurred by the
practice in the preceding 12 months.
Activities
Activity logs were provided to all staff involved in vaccination
at each practice who then recorded all time spent on vaccina-
tion specific activities over a 2-week period, which were
extracted and uploaded into Microsoft Excel for analysis.
The included activities are presented in Supplementary mate-
rial 9 – appendix 1. Vaccination appointments were grouped
into childhood appointments or adult appointments and
mean length by practice calculated, as well as the mean
between practices.
Costs
To produce cost data, the practice manager completed
a detailed survey, the components of which are presented in
Supplementary material 9 – appendix 2. All costs incurred by
the practice in the preceding complete financial year
(April 2016 to March 2017) were included, but no data were
collected on costs incurred outside the practice or by
patients.36 The costs captured were divided into facility costs
(fixed: e.g. rent, utilities), staff costs, and vaccination specific
costs (e.g. consumables). The costs of the vaccines are not
included as these are paid for by Public Health England (PHE)
and not borne by the practice or NHSE.
Steps 6 and 7 involve dividing and allocating the costs to
the vaccination activity during the study period. Firstly, we
calculated Capacity Cost Rates (CCR), defined as cost
per minute of available time. The Facility Capacity Cost
Rate (FCCR) was calculated by dividing the total annual
facility cost by the total annual appointment time delivered
by the practice (including vaccination and non-vaccination)
. This was then weighted by staff group (health-care assis-
tant (HCA), PN, GP) to account for differentials in
resource use. A nursing appointment was allocated
a weighting of 1, a GP appointment a weighting of 3 and
an HCA appointment of 0.5, based on approximate salary
differentials (HCA £16,000:PN £32,000:GP £92,500).37,38
This weighted cost per minute of activity was then multi-
plied by appointment length (minutes) to give a cost per
appointment. The Staff Capacity Cost Rate (SCCR) was
calculated by dividing annual salary and all on-costs (i.e.
employer national insurance and pension contributions), by
the total number of available working minutes per year.
Where salaries were provided without on-costs, these were
estimated by the addition of 25% to the salary figures
provided, based on advice from two PMs who participated
in the study.
For clinical time the SCCR was calculated for each staff
group based on 45 weeks worked each year, 2,250 min per
week (37.5 h, full time) and then allocated to each appoint-
ment by length. For staff admin time not attached to
a specific appointment (e.g. data uploading), the total
amount of time was proportionally allocated to each
appointment based on the number of appointments during
the study period. To calculate the vaccination specific costs,
information about the consumables used per appointment
were recorded in the staff activity logs, and practice-level
costs (e.g. fridges) were recorded in the practice manager’s
survey and allocated proportionally to each appointment.
Therefore, the cost of a vaccination appointment of
Z minutes is calculated as follows: (Z x FCCR) + (Z
x SCCR) + (specific costs per appointment). Costs were
calculated for mean appointment time spent for adult and
childhood appointments at each practice, as well as an
overall mean cost between all practices.
Sensitivity analysis
The greatest area of uncertainty in the cost model is the
weighting of facility costs by staff group resource use, as little
is known about differential resource use by GP practice staff.
We calculated the FCCR by dividing facility costs between all
the appointments delivered by the practice per year. and then
weighting based on resource use, with a GP appointment
being allocated 3 times the facility costs compared to
a nursing appointment. However, other ways of weighting
resource use by appointments, so two alternatives were eval-
uated: firstly, if GP appointments had even higher resources
use (4 times a nursing appointment) and secondly, if GP
appointments and nursing appointments had the same
resource use.
Standardization by salary
GP practices are free to negotiate staff salaries directly, which
creates variation in the amount staff are paid across the
included practices, which is not related to program delivery.
To isolate the effect of different delivery models we standar-
dized staff group salary costs, by calculating the mean salary
for each staff group (e.g. nurses, practice managers) and put
into the model in place of actual salaries. To compare stan-
dardised costs between the practices using mean salaries, the
mean cost for each component of the staff costs (clinical,
administrative) was then calculated and given a value of 1
and relative costs calculated as a proportion of the mean and
presented in Supplementary Material 7 – Table 7 (where
a value less than 1 shows a lower cost system and a value
greater than 1 a more costly system).
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Comparison with payments to practices
To evaluate practice costs against funding, the payments
made to the included practices for vaccinations in 2016–17
were extracted from routine data published by NHS
Digital.19 These are total annual payments made to indivi-
dual GP practices by NHS England for activity and out-
comes specified in the GMS contract, which includes
payments for routine vaccination. We then estimated the
total annual cost to each practice for delivering routine
vaccinations by using activity data published by NHS
England (the 2016–17 routine vaccine coverage data6) and
multiplying the mean cost at each practice for a childhood
and adult appointment calculated in this study by the total
number of annual appointments reported in the coverage
data. Timeliness data are not publicly available and given
that being vaccinated on time is high (>90%) even in lower
coverage areas,39 for simplicity we assumed that all time-
liness threshold payments were achieved.
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